MRK vs RVTY
By Alex · Tickerpine
Merck & Company, Inc. vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | RVTY |
|---|---|---|
| Price | $132.92 | $117.88 |
| Market cap | $327.94B | $13.15B |
| P/E ratio | 106.3 | 55.6 |
| ROE | 6.96% | 3.21% |
| Profit margin | 4.77% | 8.16% |
| Revenue growth | 5.10% | 1.30% |
| Dividend yield | 2.56% | 0.24% |
| Beta | 0.21 | 1.07 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs RVTY in plain English
- MRK is the bigger company — about 24.9× the market cap of RVTY.
- RVTY is cheaper on earnings (P/E 55.6 vs 106.3).
- MRK earns a higher return on equity (7% vs 3%).
- MRK is growing revenue faster (5% vs 1%).
- MRK has the higher dividend yield (2.56% vs 0.24%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.